Kura Oncology's total assets for Q4 2024 were $760.16M, an increase of 58.75% from the previous quarter. KURA total liabilities were $346.52M for the fiscal quarter, a 529.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.